Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances

• প্রধান লেখক: Yoshifumi Inoue (লেখক), Kimiko Tsuchimori (লেখক), Hiroshi Nakamura (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2021-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Schizophrenia significantly limits social functioning with positive and negative symptoms and cognitive dysfunction. Blonanserin (LONASEN®), a novel second-generation antipsychotic approved for treating schizophrenia in Japan in 2008, reportedly shows beneficial effects on cognitive function as well...